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Background: Alternative splicing (AS) is a major mechanism for modulating gene expression of an organism,
allowing the synthesis of several structurally and functionally distinct mRNAs and protein isoforms from a unique
gene. Related to AS is the Transcription Induced Chimerism (TIC) or Tandem Chimerism, by which chimeric RNAs
between adjacent genes can be found, increasing combinatorial complexity of the proteome. The Ly6g5b gene
presents particular behaviours in its expression, involving an intron retention event and being capable to form RNA
chimera transcripts with the upstream gene Csnk2b. We wanted to characterise these events more deeply in four
tissues in six different mammals and analyse their protein products.
Results: While canonical Csnk2b isoform was widely expressed, Ly6g5b canonical isoform was less ubiquitous,
although the Ly6g5b first intron retained transcript was present in all the tissues and species analysed.
Csnk2b-Ly6g5b chimeras were present in all the samples analysed, but with restricted expression patterns. Some of
these chimeric transcripts maintained correct structural domains from Csnk2b and Ly6g5b. Moreover, we found
Csnk2b, Ly6g5b, and Csnk2b-Ly6g5b transcripts that present exon skipping, alternative 5' and 3' splice site and intron
retention events. These would generate truncated or aberrant proteins whose role remains unknown. Some
chimeric transcripts would encode CSNK2B proteins with an altered C-terminus, which could affect its biological
function broadening its substrate specificity. Over-expression of human CSNK2B, LY6G5B, and CSNK2B-LY6G5B
proteins, show different patterns of post-translational modifications and cell distribution.
Conclusions: Ly6g5b intron retention and Csnk2b-Ly6g5b transcript chimerism are broadly distributed in tissues of
different mammals.Background
To date, a high number of eukaryotic genomes have been
sequenced. Surprisingly, it is interesting to observe that
Homo sapiens and Caenorhabditis elegans genomes con-
tain a similar number of protein-coding genes (~21.000),
according to the Ensembl (http://www.ensembl.org/) data-
base. Initially, these findings disconcerted researchers who
thought the number of genes should be correlated with
developmental and physiological complexity, and made
them realize that other mechanisms should be involved in
this evolutionary variety. Alternative splicing (AS) is a
major mechanism for modulating gene expression of an* Correspondence: baguado@cbm.uam.es
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distribution, and reproduction in any mediumorganism, and enables a single gene to increase its expres-
sion capacity, allowing the synthesis of several structurally
and functionally distinct mRNAs and protein isoforms
from a unique gene (For reviews see [1-3]). This mechan-
ism, which was initially described in viruses [4-6], is now
known to affect 95% of all human genes [7] and has been
proposed as a primary driver of the evolution of phenotypic
complexity in mammals [8-10]. The human Major Histo-
compatibility Complex (MHC) is located on chromosome
6, and is ~4 Mb in length. It is composed by three regions,
the class I and class II regions flanking the central class III
region. The class III region is ~0.9 Mb in length and con-
tains 62–64 genes and 2–3 pseudogenes, depending on the
haplotype [11,12]. Previously, our group precisely defined
the AS patterns of a five gene cluster from the Lymphocyte
antigen-6 (LY-6) superfamily [13] and characterised theed Central Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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and mouse. LY-6 superfamily members are cysteine-rich,
generally GPI-anchored, cell surface proteins, which have
definite or putative immune-related roles [15]. Among
these LY-6 MHC class III region genes, Ly6g5b showed a
particular behaviour in the regulation of its expression
[13,16], involving an intron retention event in human and
mouse, the rarest form of alternative splicing found in
metazoan species [17]. The intron retained is the first one
after the initial exon and interrupts the open reading frame
(ORF) just after the signal peptide introducing a premature
stop codon (PSC). The presence of a PSC at this position
should cause this intron-retained transcript to undergo
Nonsense Mediated Decay (NMD) [18,19]. However, this
transcript seemed to escape NMD and was more abundant
than the correctly spliced mRNA [13,16]. In addition, find-
ings in our laboratory showed the presence of LY6G5B gene
exons in transcripts derived from the upstream gene
CSNK2B [16], which encodes the Casein Kinase II β sub-
unit, a ubiquitous protein kinase which regulates metabolic
pathways, signal transduction, transcription, translation, and
replication [20,21]. The Transcription Induced Chimerism
(TIC) or Tandem Chimerism, is a phenomenon whose
mechanism still remains largely unknown, although it is
being promoted as a novel way to increase combinatorial
complexity of the proteome [22,23]. At least 4%-5% of the
tandem gene pairs in the human genome can be eventu-
ally transcribed into a single RNA sequence encoding a
putative chimeric protein [22] but recent bioinformatic
analyses, partially supported by experimental data, show
that this phenomenon could be quite frequent [24,25]. Re-
cently, it has been showed that these chimeras significantly
exploit signal peptides and transmembrane domains,
which could alter the cellular localisation of cognate pro-
teins, and that chimeric RNAs are more tissue specific
than non-chimeric transcripts [26]. Thus, this novel mech-
anism directly related to AS could have an important role
in evolution divergence. In this regard, the majority of
these studies give relevance to this phenomenon in Homo
sapiens [24], but detailed comparative analyses among dif-
ferent species are, to our knowledge, not described. Here,
we have deeply characterised the expression of Ly6g5b and
Csnk2b transcripts independently and of the Csnk2b-
Ly6g5b chimeric transcripts in four defined tissues among
six different mammals. We conclude that Ly6g5b intron
retention and Csnk2b-Ly6g5b chimerism is present in the
tissues of the analysed mammalian group. In addition, we
have made a comparative analysis of human CSNK2B,
LY6G5B, and CSNK2B-LY6G5B protein expressions.
Results
Csnk2b transcript analysis
Canonical Csnk2kb ORF orthologue sequences from Homo
sapiens (NM_001320), Macaca mulata (XM_001112478),Sus scrofa (XM_001928731), Bos taurus (NM_001046454),
Rattus norvegicus (NM_031021) and Mus musculus
(NM_009975) were analysed in order to find common fea-
tures among them. Comparative analysis showed a total
conservation rate in protein sequence among these six spe-
cies, except for Mus musculus which presents a unique
change in position 57 (V→ E) (Figure 1A). Through RT-
PCR analysis, we found five different transcripts for Csnk2b
in Homo sapiens, four in Macaca mulata, four in Sus
scrofa, five in Bos taurus, two in Rattus norvegicus and
three in Mus musculus (Figure 2 and Additional file 1).
Only the canonical transcript sequences were on databases,
except for Bos taurus for which BtCsnk2b-473 was also
present (see Additional file 2: Table S1). We could detect
the presence of the canonical Csnk2b transcript in each
tested species and tissues (Figure 2), and it was also the iso-
form expressed at the highest level (data not shown). In
addition, Csnk2b expression also generated other tran-
scripts (Figure 2) expressed at lower levels (data not
shown), but with a remarkable specificity among the
analysed tissues in these six species (Figure 2). Some of
them presented quite restricted expression patterns, such
as the Macaca mulata ones that are only expressed in
lung, or the Rattus norvegicus one, expressed only in brain.
By contrast, the variants from Sus scrofa, Bos taurus and
Mus musculus are broadly expressed. In Homo sapiens, the
isoform which retains intron 5 is widely expressed; how-
ever the other three are only expressed in liver and lung.
Through AS these CSNK2B transcripts present exon skip-
ping, alternative 5’ and 3’ splice site and intron retention
events (Figure 2) in the different species, which would gen-
erate severely truncated or aberrant proteins by using the
canonical start codon.
Ly6g5b transcript analysis
Canonical Ly6g5b ORF orthologue sequences from Homo
sapiens (NM_021221), Macaca mulata (XR_014070), Sus
scrofa (XM_001926307), Bos taurus (XM_585827), Rattus
norvegicus (NM_001001934) and Mus musculus (NM_148939)
were compared (Figure 1B). Although some differences in
amino acid sequence can be detected, a LY-6 protein do-
main conservation in these Ly6g5b orthologues is clearly
present (Figure 1B). This domain is composed of ~80
amino acids and is characterised by a conserved pattern of
eight to ten cysteine residues that have a defined disulfide-
bounding pattern [14]. Through RT-PCR analysis, we
found four different transcripts for Ly6g5b in Homo sapi-
ens, two in Macaca mulata, three in Sus scrofa, three in
Bos taurus, four in Rattus norvegicus and two in Mus
musculus (Figure 2 and Additional file 1). The majority
of these transcripts were not available on databases; even
the canonical sequences (see Additional file 2: Table S1).
Curiously, the presence of the canonical Ly6g5b tran-
script was only detected in three of the analysed species
AB
Figure 1 Homo sapiens (Hs), Macaca mulata (Mam), Sus scrofa (Ss), Bos taurus (Bt), Rattus norvegicus (Rn) and Mus musculus (Mum) ORF
alignments. A) Csnk2b: N-terminal region α1-α5 (5-104), juxta-dimer interface region including zinc-finger (105-147) and α6 (163-175), C-terminal
region (178-205) including interaction with CSNK2α (175-193) and dimerization (190-205) regions [27], B) Ly6g5b: The conserved cysteines,
characteristic for Ly-6 domain, are shown highlighted in grey and their connectivity with interconnected lines. Exon-exon junctions are indicated
by inverted triangles. The canonical (or theoretical canonical) sequence for each specie is only shown. The percentage of identity of each
sequence respect to the human one is shown as well as the corresponding E values.
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Similarly to what happened for Csnk2b, different transcript
variants are generated for Ly6g5b through AS. These tran-
scripts present a remarkable specificity among the analysed
tissues and species, and assuming that they could be trans-
lated into proteins starting from the first canonical start
codon, only truncated or aberrant proteins could be gener-
ated by them. Nevertheless, there is an interesting feature
that should be stressed, the retention of the first intron in
Ly6g5b transcripts, giving rise to a particular isoform (exon
1, intron 1, exon 2 and exon 3) that is present in all thetissues and analysed species (Figure 2), indicating conser-
vation, and presenting the highest expression levels (data
not shown). This isoform contains a PSC after the canon-
ical start codon, in the middle of the retained intron, and
therefore should be degraded through control mechanisms
like NMD [18,19]. However this seems not to be the case,
as we have previously described in human [16].
Csnk2b-Ly6g5b Chimeric transcript analysis
Through RT-PCR analysis, we found ten different Csnk2b-
Ly6g5b chimeric transcripts in Homo sapiens, five in
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Figure 2 Schematic representation of all Csnk2b and Ly6g5b transcripts detected through nested RT-PCR on each analysed tissue for
Homo sapiens, Macaca mulata, Sus scrofa, Bos Taurus, Rattus norvegicus and Mus musculus. White boxes represent Csnk2b, Ly6g5b and
chimera Csnk2b-Ly6g5b exons. Grey boxes represent intron sequences retained on each transcript. Red boxes indicate canonical isoforms. ORFs
are delimited by triangles (ATG codon) and hexagons (Stop codon). Squares at the left or right, represent the presence (black) or absence (white)
of expression of each transcript on the indicated tissue. Black arrows indicate Ly6g6b-Csnk2b chimeras that carry structural domains from Csnk2b
and Ly6g5b, respectively. The corresponding nucleotide and protein sequences and the accession numbers (EMBL: HE864415-HE864490) are
shown in Additional file 1.
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http://www.biomedcentral.com/1471-2164/14/199Macaca mulata, three in Sus scrofa, ten in Bos taurus, four
in Rattus norvegicus and three in Mus musculus (Figure 2
and Additional file 1). Only human Csnk2b - Ly6g5b -1181
was found on databases (see Additional file 2: Table S1). As
it happened with Csnk2b and Ly6g5b independent tran-
scripts described above, AS seems to play an important
role in generating these chimeras, and results in a set of
transcripts that greatly vary in terms of composition and
size. Indeed, exon skipping, intron retention and intergenic
region retention events are present in these transcripts.
The majority of the described chimeras (26/35) have a
common characteristic: the total lack of the last exon
(exon 7) of the upstream gene (Csnk2b) as well as the first
exon of the downstream gene (Ly6g5b). There are also
four chimeric transcripts that partially lack Csnk2b last
exon (exon 7) (two in Macaca mulata and two in Bos
taurus), one that partially maintains Ly6g5b first exon(in Macaca mulata) and four that retain the intergenic re-
gions (three in Rattus norvegicus and one in Macaca
mulata). Although chimeras function is still unknown,
some authors defend that this kind of fusion might gener-
ate bi-functional proteins which would have the properties
of both original proteins [23,26]. Assuming this, we deter-
mined the number of chimeric transcripts which con-
served the ORF of both Csnk2b and Ly6g5b genes. We
found such transcripts in Homo sapiens, Macaca mulata,
Sus scrofa and Bos taurus, of which only HsCsnk2b -
Ly6g5b -991, MamCsnk2b-Ly6g5b-992 and SsCsnk2b-
Ly6g5b-927 (Figures 2, 3 and Additional file 1) maintain
the N-terminal functional domains (alpha helices 1 to 6)
from Csnk2b (see Figures 1A and 3) [27], such as the acidic
loop (aa 55-64) and nuclear localization sequence (aa 9-14
or α1), as well as the LY-6 structural domain (see Figures 1B
and 3) [14], allowing the possibility to create potentially bi-
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Figure 3 Homo sapiens (Hs), Macaca mulata (Mam), Sus scrofa (Ss) and Bos Taurus (Bt) Csnk2b- Ly6g5b chimeras ORF alignment.
Blue and light green colour indicates Csnk2b and Ly6g5b domains, respectively. Exon-exon junctions are indicated by inverted triangles. The
conserved cysteines, characteristic for Ly-6 domain, are shown highlighted in grey and their connectivity with interconnected lines. The
percentage of identity of each sequence respect to the human one is shown as well as the corresponding E values.
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http://www.biomedcentral.com/1471-2164/14/199functional proteins [26,28,29]. These particular transcripts
which contain the same exon-intron structure are expressed
in different tissues, but commonly in brain. Bos taurus
BtCsnk2b-Ly6g5b-737 maintains only exons 1 to 3 of
Csnk2b and then would not encode its entire N-terminal
domain [27]. We did not find this type of “bi-functional”
chimeric transcripts in Rattus norvegicus or Mus musculus
(Figure 2).
It is interesting to note that several (23/35) chimeric
transcripts could encode Csnk2b truncated proteins (7/35)
or with modifications in their C-terminus (16/35). The
CSNK2B C-terminal part is involved in homodimerization
and binding to CSNK2A subunit (see Figure 1) [27]. Some
of these detected chimeric transcripts are generated by re-
placing the canonical sequence of exon 7 by sequences
encoded by total or partial exon 2 or 3 of Ly6g5b but not
corresponding to LY-6 amino-acid sequences due to changes
in the reading frames. These are chimeras HsCsnk2b-
Ly6g5b-1181, MamCsnk2b-Ly6g5b-1218, SsCsnk2b-Ly6g5b
-728, MumCsnk2b-Ly6g5b-979 and MumCsnk2b-Ly6g5b-
1108, with variable tissue distribution, except MumCsnk2b-
Ly6g5b-979 that is expressed in the four tissues. Other
transcripts are altered on Csnk2b exon 6 or 7, lacking thezinc-finger domain, α6 and C-terminal regions of CSNK2B
(see Figure 1), such as MamCsnk2b-Ly6g5b-1141 (only
expressed in brain) and BtCsnk2b-Ly6g5b-1049 (expressed
in brain and lung) which maintain the same exon-intron
structure (lack of Csnk2b exon 6 and Ly6g6b exon 1),
and SsCsnk2b-Ly6g5b-538 (expressed in the four tissues)
(see Figure 2). In addition, there are some chimeric tran-
scripts that would encode a complete CSNK2B protein
considering that they contain all exons (1-7) of Csnk2b in-
cluding the stop codon and in which the Ly6g5b nucleotide
sequences will act as 3´ UTRs. These are MamCsnk2b-
Ly6g5b-1331, MamCsnk2b-Ly6g5b-2338, BtCsnk2b-Ly6g5b
-1239, RnCsnk2b-Ly6g5b-2050, RnCsnk2b-Ly6g5b-2275 and
RnCsnk2b-Ly6g5b-2531. They present variable tissue distri-
bution and exon-intron structure (see Figure 2).
Csnk2b, Ly6g5b and Csnk2b -Ly6g5b Chimera protein
analysis
In order to analyse post-translational modifications and
sub-cellular localisation of human CSNK2B, LY6G5B and
CSNK2B-LY6G5B proteins, we over-expressed them in
the COS7 cell line (Figure 4), using a double tag strategy.
Thus, CSNK2B, LY6G5B and CSNK2B-LY6G5B proteins
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Figure 4 Human CSNK2B, LY6G5B and CSNK2B-LY6G5B chimeric protein characterisation. Schematic representation of A) V5 and Hisx6
double tag strategy. V5 (red box) and Hisx6 (yellow box) epitopes are shown. Exon numbers are indicated. B) Western-blot analysis showing
in vitro expression of CSNK2B, LY6G5B and CSNK2B-LY6G5B chimera double tagged proteins. GAPDH expression is shown as internal control.
C) Immunofluorescence experiments in permeable (P) and non permeable (NP) conditions showing CSNK2B, LY6G5B and CSNK2B-LY6G5B
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other hand, N-terminal V5 epitope was added upstream
the first ATG to CSNK2B and CSNK2B-LY6G5B proteins,
but due to the presence of a signal peptide in LY6G5B
[13] and in order to tag the mature LY6G5B protein
(Figure 4A) the V5 epitope tag was inserted after the signal
peptide. Western blot analysis using anti-V5 or anti-
PentaHis antibodies showed interesting results. Anti-V5
antibodies showed two close intense bands for CSNK2B
protein of the estimated size (Figure 4B). These two bands
could correspond to post-translational modifications of
CSNK2B such as phosphorilation [30]. For LY6G5B, also
two clear bands were also present, in agreement with previ-
ous results [14]. Interestingly, anti-V5 antibodies western-
blot analysis showed a single discrete band of the predicted
size for CSNK2B-LY6G5B protein, indicating lack of post-
translational modifications.
On the other hand, anti-PentaHis antibodies showed
similar pattern for CSNK2B protein to that showed by
anti-V5 antibodies, but no signal of LY6G5B protein orCSNK2B-LY6G5B protein was detected (Figure 4B). This
lack of detection on LY6G5B could be due to a C-terminal
processing cleaving also the Tag. This cleavage signal se-
quence would also be present in CSNK2B-LY6G5B protein
and for that also prone to be processed.
Cellular CSNK2B protein distribution has been described
before in cytoplasm, nuclei, and other organelles [21]. Our
results, through immunoflourescent confocal microscopy
experiments by using anti-V5 antibodies under perme-
abilised conditions, showed mainly cytoplasmic cellular
CSNK2B protein distribution, in agreement with previous
data [21]. Under the same conditions, LY6G5B showed a
protein distribution clearly related with ER pattern, and
not extracellular staining, as previously described [14].
Here, for the first time, we show CSNK2B-LY6G5B protein
distribution, which is quite similar to the one presented by
CSNK2B and which clearly differs from the one of the
LY6G5B protein.
Although the LY6G5B protein belongs to a GPI-
anchored protein family, it has not been found to be
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http://www.biomedcentral.com/1471-2164/14/199located on the outside of the cellular membrane [14]. In
addition, it is known that CSNK2B can be exported to the
external side of the cellular membrane [31], and CSNK2B-
LY6G5B presents CSNK2B domains needed for its export-
ation to cell surface and/or its excretion, as well as a mature
Ly-6 domain (Figure 3). To know whether CSNK2B-
LY6G5B could be on the cell surface we carried out two
experimental strategies. The first one consisted of immuno-
flourescent confocal microscopy experiments under non-
permeabilised conditions. Our results showed the absence
of CSNK2B, LY6G5B as well as CSNK2B-LY6G5B chimeric
proteins in the cell surface (Figure 4C), in COS 7 cells. The
second one was to test CSNK2B, LY6G5B and/or CSNK2B-
LY6G5B proteins presence in supernatant by western-blot
experiment. It was not possible to observe expression of
these proteins in the supernatant, either when loaded dir-
ectly on a gel or when TCA-precipitated (data not shown).
Discussion
After the challenge supposed by the human genome se-
quencing, as well as of other organisms with medical or
commercial interest, the determination of the transcrip-
tome of these species is a prerequisite for fully under-
standing not only their molecular biology, but also for
translating this information to technical applications in
medicine, pharmacology and biotechnology. In this sense,
high throughput technologies supported by systematic
cDNA libraries sequencing has been the main approach
used for transcriptome characterisation. Thus, sequencing
of random transcript cDNA clones that results in short
partial sequences, known as expressed sequence tags [32]
(EST) or, more recently, methods for full length isolation
and sequencing of random clones from cDNA libraries
have been used [33,34]. In addition, in the last few years
massive sequencing technologies have also been developed
for transcriptome analysis [7,24,35]. All these high
throughput techniques present the advantage to generate
a considerable volume of information in a relative short
time, but these techniques seem to be inefficient for dis-
covering relative rare transcripts. This affirmation is sup-
ported by recent data that suggest the existence of a
wealth of transcripts which had, so far, escaped detection
through systematic sequencing of cDNA libraries [36]. In
a recent published work [26] combining EST and RNAseq
data, it has been showed that chimeras are lowly expressed
transcripts. Thus, here we present that nested RT-PCR
shows to be an efficient tool to discover a number of tran-
scripts expressed from a concrete locus, not only those
highly expressed but also those expressed at lower levels.
In fact, 62 of 76 transcripts detected in our experiments
had never been described before. This supposes 81.5% of
novel sequences, showing how powerful this technique is
in order to detect transcripts from a concrete locus. In this
respect, our results show that current gene and transcriptannotation sets might cover only a small fraction of the
total transcriptional output of the human and other organ-
ism described genomes, and in this sense, a major enforce
should be taken in order to detect more transcripts of a
particular organism.
A detailed human and mouse Ly6g5b transcript ana-
lysis has been previously described by our group [13,16].
However, here we have extended this comparative ana-
lysis among different mammalian species, showing that
Ly6g5b first intron retention is a ubiquitous and import-
ant characteristic conserved in mammals. Its apparent
capacity to escape NMD together with its conservation
in the mammalian group studied points to an important
role for this non-coding RNA, which should be investi-
gated. So, we could conclude that Ly6g5b gene presents
a double expression pattern. The first one, quite similar
among tissues and species, is constituted by Ly6g5b tran-
scripts with first intron retention event. The second one
seems to be tissue and species specific and is constituted
by canonical Ly6g5b transcripts with a complete Ly-6
ORF as well as aberrant and non conserved transcripts,
with no common pattern distribution.
For Csnk2b gene expression we can also describe a
double expression pattern. The first one constituted by
the canonical isoform, which is quite similar among tis-
sues and species, and the second one which seems to be
tissue and species specific and is constituted by aberrant
and non conserved transcripts, with no common pattern
distribution.
CSNK2B-LY6G5B human chimerism was initially de-
scribed by Calvanesse et al (2008) by using different hu-
man cell lines [16]. However, here we show the first
comparative analysis of this TIC event using RNA from
different mammalian tissues and species. Our results show
that, far to be a human characteristic, Csnk2b-Ly6g5b chi-
merism is widely conserved in mammals. Its conservation
among all the species analysed in this study shows how
Csnk2b-Ly6g5b chimerism is not a trivial event. The major-
ity of them lack the last exon of the upstream gene as well
as the first exon of the downstream gene which is consist-
ent with previous reported data [22,23]. This eliminates the
stop codon as well as the molecular targets present in the
3’ UTR region of the transcripts of the upstream gene. We
also agree with these authors that run-off is the most likely
mechanism involved in the origin of TIC, since some
chimeric transcripts detected in our study maintain the
intergenic region. Other mechanisms proposed for gener-
ating chimeric transcripts, like trans-splicing, are not likely
to maintain these intergenic regions.
In addition to the canonical Csnk2b, Ly6g5 and Csnk2b-
Ly6g5b transcripts with a coherent ORF, other transcripts
detected in our study present exon skipping as well as in-
tron retention events which allow to generate, assuming
that all these transcripts could be translated into protein
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teins. Others are non-coding RNAs. The observation that
there are tens of thousands of non-coding RNA (ncRNA)
expressed in mammals, and that most of the genome is
transcribed, confronts and contradicts the traditional
protein-centric view of genetic information and genome
organisation [37], [38]. Thus, there are two opposing alter-
natives either the bulk of the transcription which does not
yield mRNAs is ‘transcriptional noise’ and/or the residue
of evolutionary baggage retained or accumulated within
genes, or this transcription comprises another level of ex-
pression and transaction of RNA information that is im-
portant to the evolution and developmental ontogeny of
the higher organisms [39]. If one assumes that all this is
transcriptional noise and that all these transcripts are the
result of transcriptional machinery mistakes while it is
working, they should not be distributed in a specific
manner.
Some authors defend that chimerism might generate bi-
functional proteins having properties from both original
proteins [23]. Through different analyses of our results, we
could identify chimeras which maintain the ORFs of
Csnk2b and Ly6g5b susceptible to form bi-functional
chimeric proteins in Homo sapiens, Macaca mulata, and
Sus scrofa. The fact that these were not found in cow, rat
and mouse does not indicate functional chimera absence
in these species, since they could be present in other tis-
sues not analysed in this study. These hypothetical new
chimeric proteins all carry N-terminus domains from
Csnk2b involved in structural aspects that are required for
Csnk2b exportation to the cellular surface [21] and/or its
regulation [27], as well as Ly-6 domain amino acid se-
quence [13,14] at their C-terminus. However, the chimera
“bi-functional” protein will affect the juxta-dimer interface
region [27] containing the zinc-finger involved in the
homo-dimerisation, as well as all the C-terminal domain
involved in the interaction with the CSNK2A subunits and
the crucial last 20 amino-acids also involved in the homo-
dimerisation. In addition, the Ly-6 domain, with 10
Cysteins, could not be folded as such due to the intracellu-
lar localisation. These two facts indicate that the “bi-
functional” chimera would not be formed, and would only
have one function: the one of CSNK2B, although possibly
binding to other kinase different to CSNK2A due to the al-
terations produced on the C-terminal domain commented
above. Other chimeras would only be affected from exon
7, containing then the juxta-dimer interface region but
differing at the very end C-terminal region and not
containing the Ly-6 domain sequence due to frameshifts,
and probably only affecting the binding to CSNK2A. It has
been proposed that CSNK2B might bind other kinases
such as Ras-1 and Mos to modify their catalytic affinity in
a CK2-independent fashion. The alternative C-terminal
ends, generated by the chimeric transcripts, couldincrement the binding repertoire of CSNK2B to other ki-
nases or non-kinase proteins converting CSNK2B in even
a wider “wild-card” regulator subunit than previously pro-
posed [27].
In addition, we have found chimeric transcripts that
would encode a complete CSNK2B protein, but with differ-
ent 3´UTR due to the Ly6g5b sequence, inMacaca mulata,
Bos taurus and Rattus norvegicus. These transcripts could
have different mRNA localisations or stabilities which could
have altered protein functional implications [40,41]. It has
been described that some 3´UTR contain “localization ele-
ments” or “zip codes” which target mRNAs to specific
subcellular sites.
Conclusions
Alternative splicing has an important role in Csnk2b and
Ly6g5b gene expression. Ly6g5b intron retention and
Csnk2b-Ly6g5b chimera transcripts are present in many
tissues of different mammals. The data and analysis we
have performed should serve as a valuable resource for
further characterizing the possible functional role of TIC
and the mechanisms that affect it.
Methods
Computational analysis
Csnk2b and Ly6g5b orthologue ORF sequences Homo sa-
piens, Macaca mulata, Sus scrofa, Bos taurus, Rattus
norvegicus and Mus musculus were obtained from the
National Centre for Biotechnology Information (NCBI)
(http://www.ncbi.nlm.nih.gov/BLAST/) [42]. Multiple align-
ments of sequences were performed with ClustalW2 software
(http://www.ebi.ac.uk/Tools/msa/clustalw2/) [43,44]. Protein
sequences analyses were carried out using Pfam (http://www.
sanger.ac.uk/resources/databases/pfam.html) [45], SMART
(http://smart.embl-heidelberg.de/) and InterProScan (http://
www.ebi.ac.uk/InterProScan/) [46-49] databases. The sequen-
cing results were evaluated using the BLASTalgorithm at the
NCBI web page and the MultAlin alignment software
(http://bioinfo.genotoul.fr/multalin/multalin.html) [50].
Primers were designed using the Primer3 software (www.
bioinformatics.nl/cgi-bin/primer3plus/primer3plus.cgi).
mRNA extraction and retrotranscription
Homo sapiens, Macaca mulata, Sus scrofa, Bos taurus,
Rattus norvegicus and Mus musculus brain, kidney, liver
and lung tissue total RNAs were obtained from BioChainW
(USA) http://www.biochain.com through one of their
Europe distributor "AMS" http://www.amsbio.com (UK).
One μg of total RNA from each tissue was used for oligo-
dT primed cDNA synthesis which was performed using the
ImProm-II(TM) Reverse Transcription System (Promega)
in a 20 μl reaction volume following the manufacturer's
instructions.
Table 1 Nested-PCR primers
CSNK2B LY6G5B
First Round Second Round First Round Second Round
H.sapiens F HsCSNK2BE1f01 Hs-MamCSNK2BE1-2f01 HsLY6G5BE1f01 HsLY6G5BE1f02
CGTTCCCTGGAAGTAGCAA GCTGACGTGAAGATGAGCAG GAGCATGGTCACAGGAAGGT CATCTCCCCAGAATTCCAAA
R Hs-SsCSNK2BE7r02 Hs-Mam-RnCSNK2BE7r01 HsLY6G5BE3r02 Hs-MamLY6G5BE3r01
CCCACCACAATAACGACTCC TCAGCGAATCGTCTTGACTG CGGAGGCCTAAGAAATCACA TGTTTTCAGAGAGGGCAGTG
M.mulata F MamCsnk2bE1iso1f01 Hs-MamCsnk2bE1-2f01 MamLy6g5bE1f01 MamLy6g5bE1f02
ACCCTCCCCAATTTCCACT GCTGACGTGAAGATGAGCAG TCACAGGAAGGTGGGGTTT CGTCTCCCCAGAATTCCATA
R Mam-BtCsnk2bE7r02 Hs-Mam-RnCsnk2bE7r01 MamLy6g5bE3r02 Hs-MamLy6g5bE3r01
TCCCACCACAATAATGACTCC TCAGCGAATCGTCTTGACTG CAACAGAGGGAGGCCTAAGA TGTTTTCAGAGAGGGCAGTG
S.scrofa F SsCsnk2bE1f01 SsCsnk2bE1-2f01 SsLy6g5bE1f01 SsLy6g5bE1f02
TCCTTGGAAGCAGAAACTCC CGCTGAAGTGAAGATGAGCA CTCAGGGATCACCCCTCTC TCACGTGCTCGTAGGTATGC
R Hs-SsCsnk2bE7r02 SsCsnk2bE7r01 SsLy6g5bE3r02 SsLy6g5bE3r01
CCCACCACAATAACGACTCC GGGAATCAGCGAATTGTCTT GAATGCTGGGGTCTTAGGG CCGGGAAGGATGAGATGTTA
B.taurus F BtCsnk2bE1f01 BtCsnk2bE1-2f01 BtLy6g5bE1f01 BtLy6g5bE1f02
GAAGCAGAAACTCCCCTTCC CCGACGTGAAGATGAGCAG GTCAGAACCACCCTGCAGTT CTCTCCCCAGAAGTCCATGA
R Mam-BtCsnk2bE7r02 BtCsnk2bE7r01 BtLy6g5bE3r02 BtLy6g5bE3r01
TCCCACCACAATAATGACTCC GGAATCAGCGAATCGTCTTC GGGGTGTCAGGAGTGAGATG AATCTATCTGCGACGGGAAA
R.norvegicus F Rn-MumCsnk2bE1f01 Rn-MumCsnk2bE1-2f01 RnLy6g5bBE1f01 RnLy6g5bE1f02
GTTCCTTGGAAGCACAGCTC CCGCGGACATAAAGATGAGT AGTGTGATCCCAGGAAGGTG CTACTCCACGGGAGTTGCTC
R RnCsnk2bE7r02 Hs-Mam-RnCsnk2bE7r01 RnLy6g5bE3r02 RnLy6g5bE3r01
GTGTCACAGGCAGAGGAGGT TCAGCGAATCGTCTTGACTG CCATGGAGAGCAGAAGGAAG CAGAGCAGAATCTGGGAAGG
M.musculus F Rn-MumCsnk2bE1f01 Rn-MumCsnk2bE1-2f01 MumLy6g5bE1f01 MumLy6g5bE1f02
GTTCCTTGGAAGCACAGCTC CCGCGGACATAAAGATGAGT ACTGCCTGTCAAACCCATTC TCCCCCAAATTCCATAATGA
R MumCsnk2bE7r02 MumCsnk2bE7r01 MumLy6g5bE3r02 MumLy6g5bE3r01
AGCAGAGGAATGGTGGTGTC GTGGGCAATCAGCGAATAGT GAGTGTTCACAGACCGCAGA GGGGAACACATCAGGGTCTA
Name and sequence (5’-3’ orientation). F, forward primer; R, reverse primer.
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In order to detect Csnk2b, Ly6g5b and Csnk2b-Ly6g5b
transcripts, first and second rounds of nested RT-PCR
were performed with the primers indicated on Table 1 by
using GoTaqW Green Master Mix (Promega) in a 20 μl re-
action volume. For the first round of PCR 1 μl of cDNA
was used in each reaction. Amplification conditions were:
95°C for 5 min followed by 40 cycles of 95°C for 30 s, 60°C
for 30 s and 72°C for 90 s followed by 72°C for 10 min. For
the second round of PCR, 1 μl from the first round prod-
uct diluted 1/25 was used in each PCR reaction. Amplifica-
tion conditions were the same as before but only 30 cycles
were used. PCR products were separated by size through
electrophoresis, purified from gel (WizardW SV Gel and
PCR Clean-Up System, Promega) and finally cloned into
pGEM-T Easy Vector (Promega). Sequencing of PCR
products and plasmids were carried out by the sequencing
service of the Instituto de Investigaciones Biomédicas
“Alberto Sols” (Madrid, Spain. http://www.iib.uam.es).
Expression constructs
The full-length coding sequence of human CSNK2B,
LY6G5B and CSNK2B-LY6G5B were amplified from thepreviously cloned pGEM-T Easy vectors with the spe-
cific primers showed on Table 2 by using Pfu DNA Poly-
merase (Promega). Amplification conditions were: 95°C
for 5 min followed by 35 cycles of 95°C for 30 s, 60°C
for 30 s and 74°C for 3 min followed by 74°C for 10 min.
PCR products were cloned in BamHI/AgeI cloning sites
present in pcDNA3.1/V5-His-TOPO plasmid (Invitrogen),
removing V5 epitope and in frame with the His tag creat-
ing CSNK2B-His, CSNK2B-LY6G5B-His and exon 2-exon
3 LY6G5B-His plasmids. To create a V5Tag-pcDNA3.1/
Zeo vector we designed long primers containing the V5
epitope sequence (Table 2). These primers were hybridised
(100°C for 4 min followed by 1 min cycles decreasing
0,5°C per cycle from 100°C to 4°C) to create the dsV5 Tag
sequence, which was cloned in NotI/EcoRV cloning sites
present in pcDNA3.1/Zeo(-) plasmid (Invitrogen) ending
with the V5-Tag-pcDNA3.1/Zeo vector. Then, ATG-Stop
CSNK2B-His and CSNK2B-LY6G5B-His and exon 2-exon
3 LY6G5B-His coding sequences were amplified with
primers showed on Table 2 by using Pfu DNA Polymerase
(Promega) under the same PCR conditions as above and
cloned in BamHI/HindIII cloning sites present in the new
V5-Tag-pcDNA3.1/Zeo vector in frame with the N-terminal
Table 2 Expression constructs primers
Long primers for V5 epitope cloning in pcDNA3.1/Zeo(−)
Name Sequence
MCV5_F01 GGGGCGGCCGCATGGGAAAGCCGATCCCAAACCCTCTATTAGGTCTGGACTCCACCGGATCCTGAGATATCGGG
MCV5_R01 CCCGATATCTCAGGATCCGGTGGAGTCCAGACCTAATAGAGGGTTTGGGATCGGCTTTCCCATGCGGCCGCCCC
Primers for CSNK2B, LY6G5B and CSNK2B-LY6G5B Chimera ORFs cloning in pcDNA3.1/V5-His-TOPO
Name Sequence
HsCSNK2BORF_F01 CCCGGATCCATGAGCAGCTCAGAGG
HsCSNK2BORF_R01 CCCACCGGTGCGAATCGTCTTGAC
HsLY6G5BORF_F01 CCCGGATCCATGAAGGTCCATATGC
HsLY6G5BORF_R01 CCCACCGGTGGAAGGGTGAGGTGTC
Primers for final construct in pcDNA3.1/Zeo(−)
Name Sequence
HsCSNK2BORF_F01 CCCGGATCCATGAGCAGCTCAGAGG
HsLY6G5BORFE2_F02 CCCGGATCCGTTCCTGTTCCCGACATC
Hisx6HindIIIR_01 CCCAAGCTTTCAATGGTGATGGTGATGATG
HsLY6G5BPS_F01 GGGTCTAGAATGAAGGTCCATATGC
HsLY6G5BPS_R01 CCCGCGGCCGCTCTTTCCTACTGTGAA
Restriction enzyme target sequences are in bold and italics.
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LY6G5B-His and V5-exon 2-exon 3 LY6G5B-His. Fi-
nally, LY6G5B exon 1 was amplified from LY6G5B-His
plasmid using the primers showed on Table 2 and Pfu
DNA Polymerase (Promega) under the same PCR condi-
tions described above and cloned in XbaI/NotI cloning
sites present in V5-exon 2-exon 3 LY6G5B-His plasmid to
finally create an exon1-V5-exon 2-exon 3 LY6G5B-His
vector. Sequencing of PCR products and plasmids were
carried out by the sequencing service of the Instituto de
Investigaciones Biomédicas “Alberto Sols” (Madrid, Spain.
http://www.iib.uam.es).
Transfections and western blot analyses
Transfections of COS-7 cells were carried in 24-well
plates, with 0.5 μg of plasmid per well, by using TransITW
COS Transfection kit (Mirus-BioNova) following the
manufacturer´s instructions. For Western Blot analyses,
two days after transfection, cells were harvested in
Laemmli´s SDS sample buffer. Samples were resolved on
SDS 12% (w/v) polyacrylamide gels and the proteins were
transferred onto nitrocellulose membranes (Protran).
After blocking the membrane 30 minutes in PBST (PBS-
0,05% (v/v) Tween) containing 5% (w/v) skimmed milk
powder (blocking solution), the blot was first incubated
for 90 min either in a 1/2000 dilution of mouse anti-Hisx5
(Qiagen), a 1/10000 dilution of mouse anti-V5 (Sigma) or
a 1/5000 dilution of mouse anti-GAPDH monoclonal anti-
bodies in blocking solution, washed three times for
10 min with PBST, and then incubated for 30 min in a
1:5000 dilution of peroxidase-conjugated anti-mouse IgG
antibody (Sigma) in PBST. Membrane was washed twicefor 10 min with PBST followed by a final wash in PBS for
10 min. Bound antibodies were detected by ECL Plus
Western Blotting (Amershan). Secreted proteins were TCA-
precipitated from the culture media after the addition of 1
volume of TCA to 4 volumes of media, incubated 10 min at
4°C, washed with 200 μl cold acetone, resuspended in
Laemmli´s SDS sample buffer, and analysed by SDS-
PAGE followed by Western blotting, as described above.
Immunofluorescences
Transfections were performed as described above. Two
days after transfection, cells were fixed for 15 min at
room temperature with 4% (v/v) paraformaldehyde in
PBS. Following fixation, cells were washed three times
for 15 min with PBS, treated with ammonium chloride
50 mM for 30 min and permeabilised for 20 min with
PBS containing 0.1% (v/v) Triton X-100 (wash solution).
Cells were blocked for 30 min in wash solution with 5%
(w/v) BSA (Bovine Serum Albumin, blocking solution)
and then incubated for 1 h with 1:400 dilution of mouse
anti-V5 monoclonal antibody (Sigma) in blocking solution.
After that, cells were washed three times for 15 min with
wash solution and then incubated with a secondary anti-
body coupled to Alexa 488 (anti mouse IgG, Invitrogen) in
a 1:500 dilution for 1 h in blocking solution. Cells were
washed three times for 15 min with wash solution and nu-
cleic acids were stained with To-Pro3 in a 1:500 dilution
in blocking solution. Finally, cells were washed three
times for 15 min with wash solution, mounted with Pro-
long Gold Antifade Reagent (Molecular Probes) and
photographed with a Leika confocal microscope. Non-
permeabilised immunofluorescence experiments were
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Additional files
Additional file 1: List of all the nucleotide and protein sequences of
the mRNAs described on this article with their corresponding
names and accession numbers.
Additional file 2: Table S1. Table that contains all the different spliced
isoforms detected in all the species studied in this work indicating
whether they were previously described (deposited on databases) and,
in the case they were found on databases the access number of the
corresponding sequence or of the ESTs are indicated.
Abbreviations
RT-PCR: Reverse transcription polymerase chain reaction; CDS: Coding
sequence; AS: Alternative splicing; MHC: Major Histocompatibility Complex;
ORF: Open reading frame; PSC: Premature stop codon; NMD: Nonsense
mediated decay; TIC: Transcription induced chimerism; EST: Expressed
sequence tag; cDNA: Complementary DNA; mRNA: Messenger RNA;
ncRNA: Non-coding RNA; TCA: Trichloroacetic acid; ER: Endoplasmic reticulum.
Competing interest
The authors declare that they have no competing interests.
Authors’ contributions
FH-T and AR designed and carried out the experiments, and analysed and
interpreted the data. FH-T drafted the manuscript. BA conceived the study,
participated in its design and data interpretation, and completed the
manuscript. All authors read and approved the final manuscript.
Acknowledgements
We are grateful to Fernando Carrasco from the Genomics Service at CBMSO
for his technical expertise and advice. This work was supported by grants
from the Ministerio de Educación y Ciencia (BFU2005-03683), Ministerio de
Ciencia e Innovación (BFU 2008-03126, BFU2009-09117), Comunidad de
Madrid (GR/SAL/0670/2004, and 200620 M078) and Fundación Ramón
Areces. F Hernández-Torres was funded by Genoma España and A Rastrojo
by a postgraduate fellowship (FPU) from the Ministerio de Educación y
Ciencia. B Aguado held a Programa Ramón y Cajal (MEC) contract and an
Amarouto (Comunidad Madrid-Fundación Severo Ochoa) contract. We
acknowledge support of the publication fee by the CSIC Open Access
Publication Support Initiative through its Unit of Information Resources for
Research (URICI). The CBMSO receives an institutional grant from Fundación
Ramón Areces.
Author details
1Centro de Biología Molecular Severo Ochoa (CBMSO), Consejo Superior de
Investigaciones Científicas (CSIC)-Universidad Autónoma de Madrid, Madrid,
Spain. 2Present address: Experimental Biology Department, Universidad de Jaén,
Jaén, Spain.
Received: 24 July 2012 Accepted: 13 March 2013
Published: 22 March 2013
References
1. Villate O, Rastrojo A, Lopez-Diez R, Hernandez-Torres F, Aguado B:
Differential splicing, disease and drug targets. Infect Disord Drug Targets
2008, 8(4):241–251.
2. Irimia M, Blencowe BJ: Alternative splicing: decoding an expansive
regulatory layer. Curr Opin Cell Biol 2012, 24(3):323–332.
3. Kalsotra A, Cooper TA: Functional consequences of developmentally
regulated alternative splicing. Nat Rev Genet 2011, 12(10):715–729.
4. Chow LT, Gelinas RE, Broker TR, Roberts RJ: An amazing sequence
arrangement at the 5' ends of adenovirus 2 messenger RNA. Cell 1977,
12(1):1–8.
5. Gelinas RE, Roberts RJ: One predominant 5'-undecanucleotide in
adenovirus 2 late messenger RNAs. Cell 1977, 11(3):533–544.6. Berget SM, Moore C, Sharp PA: Spliced segments at the 5' terminus of
adenovirus 2 late mRNA. Proc Natl Acad Sci USA 1977, 74(8):3171–3175.
7. Wang ET, Sandberg R, Luo S, Khrebtukova I, Zhang L, Mayr C, Kingsmore SF:
Schroth GP. Burge CB: Alternative isoform regulation in human tissue
transcriptomes. Nature; 2008.
8. Johnson JM, Castle J, Garrett-Engele P, Kan Z, Loerch PM, Armour CD,
Santos R, Schadt EE, Stoughton R, Shoemaker DD: Genome-wide survey of
human alternative pre-mRNA splicing with exon junction microarrays.
Science 2003, 302(5653):2141–2144.
9. Lander ES, Linton LM, Birren B, Nusbaum C, Zody MC, Baldwin J, Devon K,
Dewar K, Doyle M, FitzHugh W, et al: Initial sequencing and analysis of the
human genome. Nature 2001, 409(6822):860–921.
10. Venter JC, Adams MD, Myers EW, Li PW, Mural RJ, Sutton GG, Smith HO,
Yandell M, Evans CA, Holt RA, et al: The sequence of the human genome.
Science 2001, 291(5507):1304–1351.
11. Xie T, Rowen L, Aguado B, Ahearn ME, Madan A, Qin S, Campbell RD, Hood
L: Analysis of the gene-dense major histocompatibility complex class III
region and its comparison to mouse. Genome Res 2003, 13(12):2621–2636.
12. The MHC sequencing consortium: Complete sequence and gene map of a
human major histocompatibility complex. Nature 1999, 401(6756):921–923.
13. Mallya M, Campbell RD, Aguado B: Transcriptional analysis of a novel cluster
of LY-6 family members in the human and mouse major histocompatibility
complex: five genes with many splice forms. Genomics 2002, 80(1):113–123.
14. Mallya M, Campbell RD, Aguado B: Characterization of the five novel Ly-6
superfamily members encoded in the MHC, and detection of cells
expressing their potential ligands. Protein Sci 2006, 15(10):2244–2256.
15. Stroncek DF, Caruccio L, Bettinotti M: CD177: A member of the Ly-6 gene
superfamily involved with neutrophil proliferation and polycythemia
vera. J Transl Med 2004, 2(1):8.
16. Calvanese V, Mallya M, Campbell RD, Aguado B: Regulation of expression
of two LY-6 family genes by intron retention and transcription induced
chimerism. BMC Mol Biol 2008, 9:81.
17. Kim E, Magen A, Ast G: Different levels of alternative splicing among
eukaryotes. Nucleic Acids Res 2007, 35(1):125–131.
18. Lejeune F, Maquat LE: Mechanistic links between nonsense-mediated
mRNA decay and pre-mRNA splicing in mammalian cells. Curr Opin Cell
Biol 2005, 17(3):309–315.
19. Conti E, Izaurralde E: Nonsense-mediated mRNA decay: molecular insights and
mechanistic variations across species. Curr Opin Cell Biol 2005, 17(3):316–325.
20. Jakobi R, Voss H, Pyerin W: Human phosvitin/casein kinase type II.
Molecular cloning and sequencing of full-length cDNA encoding subunit
beta. Eur J Biochem 1989, 183(1):227–233.
21. Rodriguez FA, Contreras C, Bolanos-Garcia V, Allende JE: Protein kinase CK2
as an ectokinase: the role of the regulatory CK2beta subunit. Proc Natl
Acad Sci USA 2008, 105(15):5693–5698.
22. Parra G, Reymond A, Dabbouseh N, Dermitzakis ET, Castelo R, Thomson TM,
Antonarakis SE, Guigo R: Tandem chimerism as a means to increase
protein complexity in the human genome. Genome Res 2006, 16(1):37–44.
23. Akiva P, Toporik A, Edelheit S, Peretz Y, Diber A, Shemesh R, Novik A, Sorek
R: Transcription-mediated gene fusion in the human genome. Genome
Res 2006, 16(1):30–36.
24. Nacu S, Yuan W, Kan Z, Bhatt D, Rivers CS, Stinson J, Peters BA, Modrusan Z,
Jung K, Seshagiri S, et al: Deep RNA sequencing analysis of readthrough
gene fusions in human prostate adenocarcinoma and reference
samples. BMC Med Genomics 2011, 4:11.
25. Denoeud F, Kapranov P, Ucla C, Frankish A, Castelo R, Drenkow J, Lagarde J,
Alioto T, Manzano C, Chrast J, et al: Prominent use of distal 5' transcription
start sites and discovery of a large number of additional exons in
ENCODE regions. Genome Res 2007, 17(6):746–759.
26. Frenkel-Morgenstern M, Lacroix V, Ezkurdia I, Levin Y, Gabashvili A, Prilusky J,
Del Pozo A, Tress M, Johnson R, Guigo R, et al: Chimeras taking shape:
Potential functions of proteins encoded by chimeric RNA transcripts.
Genome Res 2012, 22(7):1231–1242.
27. Bolanos-Garcia VM, Fernandez-Recio J, Allende JE, Blundell TL: Identifying
interaction motifs in CK2beta–a ubiquitous kinase regulatory subunit.
Trends Biochem Sci 2006, 31(12):654–661.
28. Kumar-Sinha C, Kalyana-Sundaram S, Chinnaiyan AM: SLC45A3-ELK4 chimera in
prostate cancer: spotlight on cis-splicing. Cancer discovery 2012, 2(7):582–585.
29. Zhang Y, Gong M, Yuan H, Park HG, Frierson HF, Li H: Chimeric transcript
generated by cis-splicing of adjacent genes regulates prostate cancer
cell proliferation. Cancer discovery 2012, 2(7):598–607.
Hernández-Torres et al. BMC Genomics 2013, 14:199 Page 12 of 12
http://www.biomedcentral.com/1471-2164/14/19930. Ackerman P, Glover CV, Osheroff N: Stimulation of casein kinase II by
epidermal growth factor: relationship between the physiological activity
of the kinase and the phosphorylation state of its beta subunit. Proc Natl
Acad Sci USA 1990, 87(2):821–825.
31. Rodriguez F, Allende CC, Allende JE: Protein kinase casein kinase 2
holoenzyme produced ectopically in human cells can be exported to
the external side of the cellular membrane. Proc Natl Acad Sci USA 2005,
102(13):4718–4723.
32. Adams MD, Soares MB, Kerlavage AR, Fields C, Venter JC: Rapid cDNA
sequencing (expressed sequence tags) from a directionally cloned
human infant brain cDNA library. Nat Genet 1993, 4(4):373–380.
33. Carninci P, Kasukawa T, Katayama S, Gough J, Frith MC, Maeda N, Oyama R,
Ravasi T, Lenhard B, Wells C, et al: The transcriptional landscape of the
mammalian genome. Science 2005, 309(5740):1559–1563.
34. Kawai J, Shinagawa A, Shibata K, Yoshino M, Itoh M, Ishii Y, Arakawa T, Hara
A, Fukunishi Y, Konno H, et al: Functional annotation of a full-length
mouse cDNA collection. Nature 2001, 409(6821):685–690.
35. Mercer TR, Gerhardt DJ, Dinger ME, Crawford J, Trapnell C, Jeddeloh JA,
Mattick JS, Rinn JL: Targeted RNA sequencing reveals the deep
complexity of the human transcriptome. Nat Biotechnol 2012,
30(1):99–104.
36. Djebali S, Kapranov P, Foissac S, Lagarde J, Reymond A, Ucla C, Wyss C,
Drenkow J, Dumais E, Murray RR, et al: Efficient targeted transcript
discovery via array-based normalization of RACE libraries. Nat Methods
2008, 5(7):629–635.
37. Ecker JR, Bickmore WA, Barroso I, Pritchard JK, Gilad Y, Segal E: Genomics:
ENCODE explained. Nature 2012, 489(7414):52–55.
38. Amaral PP, Clark MB, Gascoigne DK, Dinger ME, Mattick JS: lncRNAdb: a
reference database for long noncoding RNAs. Nucleic Acids Res 2011,
39(Database issue):D146–D151.
39. Mattick JS, Makunin IV: Non-coding RNA. Hum Mol Genet 2006,
15(Spec No 1):R17–R29.
40. Holt CE, Bullock SL: Subcellular mRNA localization in animal cells and why
it matters. Science 2009, 326(5957):1212–1216.
41. Martin KC, Ephrussi A: mRNA localization: gene expression in the spatial
dimension. Cell 2009, 136(4):719–730.
42. Camacho C, Coulouris G, Avagyan V, Ma N, Papadopoulos J, Bealer K,
Madden TL: BLAST+: architecture and applications. BMC Bioinformatics
2009, 10:421.
43. Larkin MA, Blackshields G, Brown NP, Chenna R, McGettigan PA, McWilliam
H, Valentin F, Wallace IM, Wilm A, Lopez R, et al: Clustal W and Clustal X
version 2.0. Bioinformatics 2007, 23(21):2947–2948.
44. Goujon M, McWilliam H, Li W, Valentin F, Squizzato S, Paern J, Lopez R: A
new bioinformatics analysis tools framework at EMBL-EBI. Nucleic Acids
Res 2010, 38(Web Server issue):W695–W699.
45. Finn RD, Mistry J, Tate J, Coggill P, Heger A, Pollington JE, Gavin OL,
Gunasekaran P, Ceric G, Forslund K, et al: The Pfam protein families
database. Nucleic Acids Res 2010, 38(Database issue):D211–D222.
46. Bucher P, Karplus K, Moeri N, Hofmann K: A flexible motif search
technique based on generalized profiles. Comput Chem 1996, 20(1):3–23.
47. Scordis P, Flower DR, Attwood TK: FingerPRINTScan: intelligent searching
of the PRINTS motif database. Bioinformatics 1999, 15(10):799–806.
48. Eddy SR: Profile hidden Markov models. Bioinformatics 1998, 14(9):755–763.
49. Altschul SF, Madden TL, Schaffer AA, Zhang J, Zhang Z, Miller W, Lipman DJ:
Gapped BLAST and PSI-BLAST: a new generation of protein database
search programs. Nucleic Acids Res 1997, 25(17):3389–3402.
50. Corpet F: Multiple sequence alignment with hierarchical clustering.
Nucleic Acids Res 1988, 16(22):10881–10890.
doi:10.1186/1471-2164-14-199
Cite this article as: Hernández-Torres et al.: Intron retention and
transcript chimerism conserved across mammals: Ly6g5b and
Csnk2b-Ly6g5b as examples. BMC Genomics 2013 14:199.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
